Darmerica, LLC recalls Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-5…
- Recall date
- September 6, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0125-2020
- FDA classification
- Class I
- Brand / firm
- Darmerica, LLC
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707
Get recall alerts
Free email alert whenever Darmerica, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Darmerica, LLC